India's Marksans Pharma set for worst day in 4 years as profit drops
** Shares of Marksans Pharma MARK.NS slide 11.4%
** Stock set for biggest one-day drop since March 2020
** Drugmaker posts 4.5% Y/Y fall in Q4 profit
** Rev rises 15.2%, but is outpaced by costs jumping 21.3%
** Stock reverses course to YTD losses; now down ~5% YTD
** Stock had surged ~177% in 2023, its best year since 2020
(Reporting by Yagnoseni Das in Bengaluru)
((Yagnoseni.Das@thomsonreuters.com))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg